The Bulgarian Yogurt Story Behind Modern Probiotic Science

There is a detail in probiotic research that feels almost too fitting to be true: the entire modern probiotics industry, now worth billions of dollars, traces part of its origin story back to Bulgaria. A 2025 review published in Gut Microbes, by Amanda Lee, Daphne Rodriguez Jimenez, and Marlies Meisel, opens with exactly this history before turning to one of the most studied probiotic strains in immune research today, Limosilactobacillus reuteri.

Where the story starts: a Nobel laureate and sour milk

In the early 1900s, Nobel Laureate Élie Metchnikoff noticed something that intrigued him: villagers in Bulgaria who regularly consumed sour milk, fermented by Lactobacilli bacteria, seemed to live unusually long lives. Metchnikoff connected the dots between this fermented dairy tradition and longevity, a hypothesis that, over the following century, helped launch the entire field of probiotic science. What began as an observation about a regional dietary habit eventually grew into a global, multibillion-dollar industry built around the idea that specific live bacteria, deliberately consumed, can meaningfully shape human health.

It is worth pausing on that origin, not just because of where it took place, but because it is a good example of how much of nutrition science actually starts: not in a lab, but in the careful observation of a population living unusually well, followed by decades of research trying to understand why.

From sour milk to a specific, well-studied strain

More than a century after Metchnikoff's observation, researchers have moved from broad fermented-food traditions to studying individual bacterial strains in precise detail. One of the most extensively researched is Limosilactobacillus reuteri, commonly abbreviated L. reuteri, a naturally occurring gut bacterium found in the human microbiome.

This review focuses specifically on how L. reuteri interacts with the immune system, an area where the research has become particularly rich, especially regarding two major categories of disease: autoimmunity and cancer.

What makes L. reuteri interesting to immunologists

The immune system's job is a constant balancing act. It needs to be aggressive enough to fight off pathogens and abnormal cells, but restrained enough not to attack the body's own healthy tissue, which is what happens in autoimmune disease. What the review highlights is that L. reuteri appears to have what researchers describe as contextual, systemic immune-regulatory properties, meaning its effect on the immune system is not a single, one-directional action, but something that shifts depending on the surrounding biological context.

This dual, context-sensitive relevance is part of what makes L. reuteri such an active area of study:

• In the context of autoimmunity, where the immune system has become miscalibrated and begins attacking the body's own tissue, researchers are interested in whether L. reuteri can help restore a more balanced, appropriately regulated immune response.
  

• In the context of cancer, where part of the therapeutic challenge is getting the immune system to properly recognize and respond to abnormal cells, researchers are exploring whether L. reuteri can support or enhance immune activity in a beneficial direction.
  

The fact that the same organism is being studied for its potential role in two seemingly opposite problems, an immune system that is too reactive in one case and possibly under-responsive in another, speaks to how nuanced and context-dependent gut-immune interactions actually are. This is not a bacterium with one simple effect; it is one whose impact depends heavily on the surrounding physiological environment.

An important note on where the evidence actually stands

This is a review article synthesizing existing research, much of which comes from mechanistic and preclinical studies, rather than a single large-scale clinical trial in humans. The relationship between L. reuteri and conditions like autoimmunity and cancer is an active, evolving area of investigation, not a settled clinical recommendation. The honest framing is that this is a genuinely promising research direction with a compelling scientific rationale, not yet a proven therapeutic protocol for any specific disease.

Why the Metchnikoff story still matters

There is something meaningful in the fact that this entire scientific thread began with a simple, observed pattern: people in a particular place, eating a particular fermented food, seemed to live longer. More than a hundred years of increasingly sophisticated research later, scientists are still working to understand exactly why, now down to the level of individual bacterial strains and their precise interactions with the immune system.

It is also a quiet reminder that some of what we now frame as cutting-edge longevity science has deep roots in traditional food practices that were never marketed as "longevity interventions" at all. They were simply how people ate. The science has since caught up to explain some of what was likely always working quietly in the background.

Source: Lee AH, Rodriguez Jimenez DM, Meisel M. "Limosilactobacillus reuteri - a probiotic gut commensal with contextual impact on immunity." Gut Microbes. 2025. PMID: 39825615.